Results 111 to 120 of about 1,404 (176)
Impact of Sex on Prediction of Asthma Attacks by Clinical Risk Factors and Type 2 Biomarkers. [PDF]
ChestRiemann S, Meulmeester FL, Mailhot-Larouche S, Ramakrishnan S, Wechsler ME, Corren J, Diver SE, Brightling CE, Castro M, Hanania NA, Jackson DJ, Martin N, Laugerud A, Clarke D, Moore A, Hardin ME, Holweg CTJ, Allu S, Hinks TSC, Beasley RW, Sont JK, Steyerberg EW, Pavord ID, Brusselle G, Couillard S, OxfoRd Asthma attaCk risk scaLE Meta-Analysis (ORACLE2) Consortium. +25 moreeuropepmc +1 more sourceCommunity-based prediction models of cardiovascular events, acute exacerbations and all-cause mortality in individuals with chronic obstructive pulmonary disease: a systematic review and meta-analysis on behalf of the International Cardiovascular and Respiratory Alliance. [PDF]
BMJ Open Respir ResJoseph T, Raveendra K, Haris M, Kirupananthan J, Aslam A, Mircescu A, Bhardwaj A, Wong A, Nadarajah R, Price DB, Bhutani M, Gale C. +11 moreeuropepmc +1 more sourceSERPINE1 promoter variants and differential airway responses to virus and biological therapy. [PDF]
J Allergy Clin ImmunolThames AH, Schutt M, Gadd S, Barrera L, Cho S, Wentworth-Sheilds W, Pongracic J, Liu AH, Gruchalla R, Kercsmar C, Hershey GK, Zoratti E, Johnson C, Teach S, Kattan M, Nodzenski M, Gaberino C, Bacharier L, O'Connor GT, Gern J, Visness C, Coleman A, Gergen P, Becker P, Ober C, Jackson D, Altman M, Kumar R. +27 moreeuropepmc +1 more sourcePrediction Pathway for Severe Asthma Exacerbations: A Bayesian Network Analysis. [PDF]
ChestYadav CP, Chakraborty A, Price DB, Lim LHM, Juang YR, Beasley R, Sadatsafavi M, Janson C, Siyue MK, Wang E, Wechsler ME, Jackson DJ, Busby J, Heaney LG, Pfeffer PE, Mahboub B, Perng DW, Cosio BG, Perez-de-Llano L, Al-Lehebi R, Larenas-Linnemann D, Al-Ahmad MS, Rhee CK, Iwanaga T, Heffler E, Canonica GW, Costello RW, Papadopoulos NG, Papaioannou AI, Porsbjerg CM, Torres-Duque CA, Christoff GC, Popov TA, Hew M, Peters MJ, Gibson PG, Máspero J, Bergeron C, Cerda S, Contreras EA, Chen W. +40 moreeuropepmc +1 more sourceMulticentre, 2×2 factorial, randomised, open-label trial of neuromodulators and cough control therapy for refractory or unexplained chronic cough: the FORTITUDE trial protocol. [PDF]
BMJ OpenKum E, Hassan W, Beaudin S, Strong G, Smith K, Oliveira A, Al-Saiedy M, Mancopes R, Grave AS, Bernier M, Bhalla A, Brister DL, Côté A, Couillard S, Field SK, Johnston F, Newman R, Popovic N, Kaplan AG, Brooks D, Guyatt G, Satia I. +21 moreeuropepmc +1 more source